Developing regions vs El Salvador: Proportion of the target population who received a 3rd dose of
Developing regions
66.0%
in 2024
El Salvador
96.0%
in 2024
Developing regions rank
24th
El Salvador rank
16th
Proportion of the target population who received a 3rd dose of over time
- Developing regions
- El Salvador
How they compare
El Salvador currently reports 96.0% against 66.0% in Developing regions, a difference of 30.0%.
That makes El Salvador's figure about 1.5 times Developing regions's.
Across all 15 years both countries report, El Salvador has been ahead every year.
Developing regions ranks 24th and El Salvador ranks 16th of 37 groups.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developing regions | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.4% | 91.0% | 62.6% | El Salvador |
| 2020s | 56.4% | 94.0% | 37.6% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Developing regions or El Salvador?
- El Salvador, at 96.0% against 66.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Developing regions and El Salvador?
- 30.0%, with El Salvador ahead.
- How many years of comparable data are there for Developing regions and El Salvador?
- 15 years are reported by both, from 2010 to 2024.
- How do Developing regions and El Salvador rank globally for proportion of the target population who received a 3rd dose of?
- Developing regions ranks 24th and El Salvador ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.